Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities (Tables)

v3.24.1.u1
Cash, Cash Equivalents, Restricted Cash and Marketable Debt Securities (Tables)
 3 Months Ended
Mar. 31, 2024
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the Condensed Consolidated Balance Sheets to the total of the amounts in the Condensed Consolidated Statements of Cash Flows as of March 31, 2024, December 31, 2023, March 31, 2023 and December 31, 2022:

 

    March 31,
2024		     December 31,
2023		     March 31,
2023		     December 31,
2022		  
Cash and cash equivalents   $ 1,071     $ 4,787     $ 5,739     $ 6,830  
Restricted cash included in current/non-current assets     250       250       250       250  
Cash, cash equivalents and restricted cash in the statement of cash flows   $ 1,321     $ 5,037     $ 5,989     $ 7,080  
Schedule of Marketable Debt Securities

The following tables summarize the Company’s marketable debt securities as of March 31, 2024:

 

    Amortized Cost     Unrealized Gain     Unrealized (Loss)     Fair Value  
    Amortized     Unrealized     Unrealized        
    Cost     Gain     (Loss)     Fair Value  
U.S. Government Notes   $ 7,173     $ —     $ (134 )   $ 7,039  
Total marketable debt securities   $ 7,173     $ —     $ (134 )   $ 7,039  
The following tables summarize the Company’s marketable debt securities as of December 31, 2023:

 

    Amortized     Unrealized     Unrealized        
    Cost     Gain     (Loss)     Fair Value  
U.S. Treasury Bonds   $ 999     $ —     $ (3 )   $ 996  
U.S. Government Notes     8,191       —       (218 )     7,973  
Total marketable debt securities   $ 9,190     $ —     $ (221 )   $ 8,969